title: [Echinocandins: Applied pharmacology].
abstract: The echinocandins share pharmacodynamic properties, although there are some interesting differences in their pharmacokinetic behaviour in the clinical practice. They are not absorbed by the oral route. They have a somewhat special distribution in the organism, as some of them can reach high intracellular concentrations while, with some others, the concentration is reduced. They are highly bound to plasma proteins, thus it is recommended to administer a loading dose for anidulafungin and caspofungin, although this procedure is not yet clear with micafungin. Echinocandins are excreted via a non-microsomal metabolism, so the urinary concentration is very low. Some carrier proteins that take part in the biliary clearance process are probably involved in the interactions described with caspofungin and micafungin. These two drugs must be used with caution in patients with severely impaired hepatic function, while all of them can be used without special precautions when there is renal impairment or the patient requires renal replacement therapy.
authors.affiliation: Servicio de Farmacología Clínica, Clínica Universidad de Navarra, Pamplona, Navarra, España. Electronic address: jrazanza@unav.es.
authors.forename: José Ramón
authors.initials: JR
authors.lastname: Azanza Perea
mesh_terms: D000935:Antifungal Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D054714:Echinocandins / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins
keywords: Antifungal drugs; Antifúngicos; Echinocandins; Equinocandinas; Farmacología; Pharmacology